| J01FA10 |
Azithromycin |
Azitrox 250 |
Film coated tablet |
250 |
mg |
6 |
Zentiva k.s., Чешка република |
300 |
mg |
- |
10.73 |
1.83794 |
9.19 |
25% |
2.3 |
|
H66.0,J03,J15,J16,J40,J42,K25.7,K26 |
КЦРР-2727/20.03.2013 г.; НСР-942/12.08.2013 |
16.09.2013 |
08.09.2012 |
|
Заличен |
2365 |
| J01FA10 |
Azithromycin |
Azitrox 250 |
Film coated tablet |
250 |
mg |
3 |
Zentiva k.s., Чешка република |
300 |
mg |
- |
7.12 |
1.396 |
3.49 |
25% |
0.87 |
|
H66.0,J03,J15,J16,J40,J42,K25.7,K26 |
НСР-931/12.08.2013;НСР-1353/07.10.2013 |
02.11.2013 |
08.09.2012 |
|
Заличен |
2366 |
| J01FA10 |
Azithromycin |
Azitrox 500 |
Film coated tablet |
500 |
mg |
3 |
Zentiva k.s., Чешка република |
300 |
mg |
- |
10.14 |
1.83794 |
9.19 |
25% |
2.3 |
|
H66.0,J03,J15,J16,J40,J42,K25.7,K26 |
КЦРР-2728/20.03.2013 г.; НСР-942/12.08.2013 |
16.09.2013 |
08.09.2012 |
|
Заличен |
2276 |
| J01FA10 |
Azithromycin |
J01FA10 Azithromycin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J01FA10 |
Azithromycin |
AZATRIL |
Powder for oral suspension |
200 mg/5 ml - 20 ml |
mg |
1 |
Актавис EАД, България |
300 |
mg |
- |
15.28 |
3.9855 |
10.63 |
25% |
2.66 |
за деца до 8 г. |
H66.0,J03.0,J03.8,J03.9,J15.2,J15.3,J15.4,J15.6,J15.7,J15.8,J16.0,J16.8,J40,J42,K25.7,K26.7 |
НСР-1775/21.1.2013 |
16.12.2013 |
08.09.2012 |
|
Заличен |
214 |
| J01FA10 |
Azithromycin |
AZATRIL |
Powder for oral suspension |
100 mg/5 ml - 20 ml |
mg |
1 |
Актавис EАД, България |
300 |
mg |
- |
11.89 |
3.9855 |
5.31 |
25% |
1.33 |
за деца до 8 г. |
H66.0,J03.0,J03.8,J03.9,J15.2,J15.3,J15.4,J15.6,J15.7,J15.8,J16.0,J16.8,J40,J42,K25.7,K26.7 |
НСР-1775/21.1.2013 |
16.12.2013 |
08.09.2012 |
|
Заличен |
213 |
| J01FA10 |
Azithromycin |
BINOZYT |
Powder for oral suspension |
200 mg/5 ml - 20 ml |
mg |
1 |
Sandoz d.d., Словения |
300 |
mg |
- |
12.58 |
3.9855 |
10.63 |
25% |
2.66 |
за деца до 8 г. |
H66.0,J03.0,J03.8,J03.9,J15.2,J15.3,J15.4,J15.6,J15.7,J15.8,J16.0,J16.8,J40,J42,K25.7,K26.7 |
№ 151/ 14.03.2011; НСР-818/07.08-2013; НСР-2233/20.12.2013 |
16.01.2014 |
08.09.2012 |
|
Заличен |
1999 |
| J01FA10 |
Azithromycin |
BINOZYT |
Powder for oral suspension |
100 mg/5 ml - 20 ml |
mg |
1 |
Sandoz d.d., Словения |
300 |
mg |
- |
9.8 |
3.9855 |
5.31 |
25% |
1.33 |
за деца до 8 г. |
H66.0,J03.0,J03.8,J03.9,J15.2,J15.3,J15.4,J15.6,J15.7,J15.8,J16.0,J16.8,J40,J42,K25.7,K26.7 |
№ 151/ 14.03.2011; НСР-2234/20.12.2013 |
16.01.2014 |
08.09.2012 |
|
Заличен |
914 |
| J01FA10 |
Azithromycin |
Sumamed forte syrup |
Granules for oral suspension |
200 mg/ 5 ml - 15 ml |
mg |
1 |
Pliva Ljubljana d.o.o., Словения |
300 |
mg |
- |
11.41 |
3.9855 |
7.97 |
25% |
1.99 |
за деца до 8 г. |
H66.0,J03,J15,J16,J40,J42,K25.7,K26 |
№ 202/ 19.10.2011.;КЦРР-1248/15.08.2012 |
14.09.2012 |
08.09.2012 |
|
Заличен |
990 |
| J01FA10 |
Azithromycin |
Sumamed syrup |
Powder for oral suspension |
100 mg/ 5 ml - 20 ml |
mg |
1 |
Pliva Ljubljana d.o.o., Словения |
300 |
mg |
- |
11.59 |
3.9855 |
5.31 |
25% |
1.33 |
за деца до 8 г. |
H66.0,J03,J15,J16,J40,J42,K25.7,K26 |
КЦРР-784/15.06.2012 г.;КЦРР-1248/15.08.2012 |
14.09.2012 |
08.09.2012 |
|
Заличен |
1249 |
| J01FA10 |
Azithromycin |
ZMAX |
|
2 g/60 ml |
mg |
1 |
Pfizer Europe MA EEIG, Обединено Кралство |
300 |
mg |
- |
26.57 |
3.9855 |
26.57 |
25% |
6.64 |
|
H66.0,J03.0,J03.8,J03.9,J15.2,J15.3,J15.4,J15.6,J15.7,J15.8,J16.0,J16.8,J40,J42,K25.7,K26.7 |
№25/03.08.2009.
№ 35/21.08.2009; НСР-3229/14.04.2014 |
16.05.2014 |
08.09.2012 |
|
Заличен |
657 |
| J01FF01 |
Clindamycin |
J01FF01 Clindamycin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J01FF01 |
Clindamycin |
Clindamycin ABR 600 mg |
Capsule, hard |
600 |
mg |
30 |
Антибиотик Разград АД, България |
1200 |
mg |
- |
44.71 |
1.945 |
29.18 |
25% |
7.29 |
J03 - до 18 години |
A38,J03.0,J03.8,J03.9,J15.2,J15.3,J15.4,J15.7,J15.8,J16.0,J16.8,J40,J42 |
НСР-3936/30.06.2014; НСР-9240/05.05.2016 |
02.06.2016 |
|
|
Заличен |
2985 |
| J01FF01 |
Clindamycin |
Clindamycin ABR 600 mg |
Capsule, hard |
300 |
mg |
16 |
Антибиотик Разград АД, България |
1200 |
mg |
- |
7.78 |
1.945 |
7.78 |
25% |
1.95 |
J03 - до 18 години |
A38,J03.0,J03.8,J03.9,J15.2,J15.3,J15.4,J15.7,J15.8,J16.0,J16.8,J40,J42 |
НСР-3937/30.06.2014; НСР-9240/05.05.2016 |
02.06.2016 |
|
|
Заличен |
2987 |
| J01FF01 |
Clindamycin |
Clindamycin ABR 600 mg |
Capsule, hard |
600 |
mg |
12 |
Антибиотик Разград АД, България |
1200 |
mg |
- |
16.14 |
1.945 |
11.67 |
25% |
2.92 |
J03 - до 18 години |
A38,J03.0,J03.8,J03.9,J15.2,J15.3,J15.4,J15.7,J15.8,J16.0,J16.8,J40,J42 |
НСР-3936/30.06.2014; НСР-9240/05.05.2016 |
02.06.2016 |
|
|
Заличен |
2986 |
| J01FF01 |
Clindamycin |
CLINDAMYCIN ACTAVIS |
Capsule, hard |
150 |
mg |
16 |
Актавис EАД, България |
1200 |
mg |
- |
8.94 |
2.4325 |
4.87 |
25% |
1.22 |
|
A38,J03,J15,J16,J40,J42 |
КЦРР-1445/02.10.2012. |
24.10.2012 |
08.09.2012 |
|
Заличен |
215 |
| J01FF01 |
Clindamycin |
CLINDAMYCIN - MIP |
Film coated tablet |
600 |
mg |
30 |
Chephazaar ChemPharm Fabrik GmbH,, Германия |
1200 |
mg |
- |
44.75 |
1.945 |
29.18 |
25% |
7.29 |
J03 - до 18 години |
A38,J03.0,J03.8,J03.9,J15.2,J15.3,J15.4,J15.7,J15.8,J16.0,J16.8,J40,J42 |
№ 204/ 24.10.2011; НСР-1428/10.10.2013; НСР-9239/05.05.2016 |
02.06.2016 |
08.09.2012 |
|
Заличен |
2576 |
| J01FF01 |
Clindamycin |
CLINDAMYCIN - MIP |
Film coated tablet |
300 |
mg |
16 |
Chephazaar ChemPharm Fabrik GmbH,, Германия |
1200 |
mg |
- |
10.58 |
1.945 |
7.78 |
25% |
1.95 |
J03 - до 18 години |
A38,J03.0,J03.8,J03.9,J15.2,J15.3,J15.4,J15.7,J15.8,J16.0,J16.8,J40,J42 |
№ 204/ 24.10.2011; НСР-3045/21.03.2014; НСР-9239/05.05.2016 |
02.06.2016 |
08.09.2012 |
|
Заличен |
2670 |
| J01FF01 |
Clindamycin |
CLINDAMYCIN - MIP |
Film coated tablet |
600 |
mg |
12 |
Chephazaar ChemPharm Fabrik GmbH,, Германия |
1200 |
mg |
- |
14.89 |
1.945 |
11.67 |
25% |
2.92 |
J03 - до 18 години |
A38,J03.0,J03.8,J03.9,J15.2,J15.3,J15.4,J15.7,J15.8,J16.0,J16.8,J40,J42 |
№ 204/ 24.10.2011; НСР-1427/10.10.2013; НСР-3045/21.03.2014; НСР-9239/05.05.2016 |
02.06.2016 |
08.09.2012 |
|
Заличен |
2669 |
| J01FF01 |
Clindamycin |
Dalacin C |
Capsule, hard |
300 |
mg |
16 |
Pfizer Enterprises SARL, Люксембург |
1200 |
mg |
- |
9.73 |
2.4325 |
9.73 |
25% |
2.43 |
J03 - до 18 години |
A38,J03.0,J03.8,J03.9,J15.2,J15.3,J15.4,J15.7,J15.8,J16.0,J16.8,J40,J42 |
НСР-3236/14.04.2014 |
16.05.2014 |
08.09.2012 |
|
Заличен |
599 |
| J01FF01 |
Clindamycin |
Dalacin C |
Capsule, hard |
150 |
mg |
16 |
Pfizer Enterprises SARL, Люксембург |
1200 |
mg |
- |
5.87 |
2.4325 |
4.87 |
25% |
1.22 |
J03 - до 18 години |
A38,J03.0,J03.8,J03.9,J15.2,J15.3,J15.4,J15.7,J15.8,J16.0,J16.8,J40,J42 |
НСР-3237/14.04.2014 |
16.05.2014 |
08.09.2012 |
|
Заличен |
598 |
| J01FF01 |
Clindamycin |
J01FF01 Clindamycin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J01FF01 |
Clindamycin |
Dalacin C |
Granules for syrup |
75 mg/5 ml - 80 ml |
mg |
1 |
Pfizer Enterprises SARL, Люксембург |
1 |
mg |
- |
11.57 |
0.00964 |
11.57 |
25% |
2.89 |
за деца до 8 години |
A38,J03.0,J03.8,J03.9,J15.2,J15.3,J15.4,J15.7,J15.8,J16.0,J16.8,J40 |
НСР-7378/05.11.2015 |
02.12.2015 |
08.09.2012 |
|
Заличен |
600 |
| J01FF02 |
Lincomycin |
J01FF02 Lincomycin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J01FF02 |
Lincomycin |
LINCOMYCIN ACTAVIS |
Capsule, hard |
500 |
mg |
20 |
Актавис EАД, България |
1800 |
mg |
- |
9.24 |
1.6632 |
9.24 |
25% |
2.31 |
|
A38,J03.0,J03.8,J03.9,J15.2,J15.3,J15.4,J15.7,J15.8,J16.0,J16.8,J40,J42 |
НСР-1837/25.11.2013 |
16.12.2013 |
08.09.2012 |
|
Заличен |
222 |